165 related articles for article (PubMed ID: 38068922)
1. Therapeutic Potential of Resveratrol for Glioma: A Systematic Review and Meta-Analysis of Animal Model Studies.
Luís Â; Marcelino H; Domingues F; Pereira L; Cascalheira JF
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068922
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
Hirst TC; Vesterinen HM; Sena ES; Egan KJ; Macleod MR; Whittle IR
Br J Cancer; 2013 Jan; 108(1):64-71. PubMed ID: 23321511
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.
Merenzon MA; Hincapie Arias E; Bhatia S; Shah AH; Higgins DMO; Villaverde M; Belgorosky D; Eijan AM
Nitric Oxide; 2023 Sep; 138-139():10-16. PubMed ID: 37279819
[TBL] [Abstract][Full Text] [Related]
6. The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Luís Â; Marcelino H; Rosa C; Domingues F; Pereira L; Cascalheira JF
Eur J Pharmacol; 2020 Jun; 876():173055. PubMed ID: 32145324
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
8. Action of Curcumin on Glioblastoma Growth: A Systematic Review with Meta-Analysis of Animal Model Studies.
Luís Â; Amaral L; Domingues F; Pereira L; Cascalheira JF
Biomedicines; 2024 Jan; 12(2):. PubMed ID: 38397870
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth.
Figueiró F; Bernardi A; Frozza RL; Terroso T; Zanotto-Filho A; Jandrey EH; Moreira JC; Salbego CG; Edelweiss MI; Pohlmann AR; Guterres SS; Battastini AM
J Biomed Nanotechnol; 2013 Mar; 9(3):516-26. PubMed ID: 23621009
[TBL] [Abstract][Full Text] [Related]
10. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP
Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386
[TBL] [Abstract][Full Text] [Related]
11. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
12. The Plant-Derived Compound Resveratrol in Brain Cancer: A Review.
Kiskova T; Kubatka P; Büsselberg D; Kassayova M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963897
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of a mouse model bearing orthotopic temozolomide-resistant glioma].
Shi L; Li H; Gu J; Song C; Li J; Chen L; Zhou Q; Qi S; Lu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):69-74. PubMed ID: 33509755
[TBL] [Abstract][Full Text] [Related]
14. Comparison of corticotropin-releasing factor, dexamethasone, and temozolomide: treatment efficacy and toxicity in U87 and C6 intracranial gliomas.
Moroz MA; Huang R; Kochetkov T; Shi W; Thaler H; de Stanchina E; Gamez I; Ryan RP; Blasberg RG
Clin Cancer Res; 2011 May; 17(10):3282-92. PubMed ID: 21385926
[TBL] [Abstract][Full Text] [Related]
15. PCC0208009 enhances the anti-tumor effects of temozolomide through direct inhibition and transcriptional regulation of indoleamine 2,3-dioxygenase in glioma models.
Sun S; Du G; Xue J; Ma J; Ge M; Wang H; Tian J
Int J Immunopathol Pharmacol; 2018; 32():2058738418787991. PubMed ID: 29993291
[TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y
Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456
[TBL] [Abstract][Full Text] [Related]
17. Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.
Ouyang M; White EE; Ren H; Guo Q; Zhang I; Gao H; Yanyan S; Chen X; Weng Y; Da Fonseca A; Shah S; Manuel ER; Zhang L; Vonderfecht SL; Alizadeh D; Berlin JM; Badie B
PLoS One; 2016; 11(2):e0148139. PubMed ID: 26829221
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
19. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.
Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A
BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
